EUIPO trademark

BEXCOVEV

Opposition periodEUIPOWord markClass 5

"BEXCOVEV" is a word mark owned by Regeneron Pharmaceuticals, filed at the EUIPO on August 14, 2026. It is in its opposition period and covers class 5 (Pharmaceuticals).

Official EUIPO record
BEXCOVEV
Word mark as filed with the EUIPO
Status
Opposition period
Filed
August 14, 2026
Registered
Not yet
Expires
Not recorded
Application no.
019409547
Registration no.
Not yet
Office
EUIPO
European Union Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns BEXCOVEV

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services BEXCOVEV is filed for, grouped by Nice class.

History

What has happened so far

Steps recorded by the EUIPO, newest first.

  1. Bulletin 2026/158 Section A.1
FAQ

About BEXCOVEV

Who owns the trademark "BEXCOVEV"?

The EUIPO trademark "BEXCOVEV" (application 019409547) is owned by Regeneron Pharmaceuticals.

What is the status of "BEXCOVEV"?

Its status at the EUIPO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull BEXCOVEV and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_01a0043d-8b40-75cf-ba6b-230e9e55e538
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a0043d-8b40-75cf-ba6b-230e9e55e538",
  "object": "trademark",
  "mark_text": "BEXCOVEV",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "EM",
  "application_number": "019409547",
  "filing_date": "2026-08-14",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Regeneron Pharmaceuticals",
      "entity_id": "ent_019f7564-a0e8-7575-a3fd-12ec6e80fa07"
    }
  ]
}